Live vaccines are a concern with Cosentyx, a medication used to treat several immune-mediated inflammatory conditions, due to the potential risk of developing infections. Cosentyx, also known as secukinumab, is a biologic drug that works by inhibiting a specific protein involved in inflammation [1].

According to the Cosentyx website, individuals taking Cosentyx may have a reduced immune response to live vaccines and may be more likely to develop infections from these vaccines [2]. Therefore, it is recommended to avoid live vaccines during and for a certain period after Cosentyx treatment.

A study published in the Journal of Allergy and Clinical Immunology: In Practice supports this information, stating that biologic therapies, including Cosentyx, can increase the risk of infections and reactivation of latent viruses [3]. The study also notes that live vaccines should be avoided during biologic therapy.

In summary, live vaccines are a concern with Cosentyx due to the potential increased risk of infections. It is recommended to avoid live vaccines during and for a certain period after Cosentyx treatment [2][3].

Sources:

1. <https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX>
2. <https://www.cosentyx.com/all/covid19>
3. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767096/>